Cargando…

Potential Anticancer Activities and Catalytic Oxidation Efficiency of Platinum(IV) Complex

The treatment of an aqueous acetonitrile solution of chloroplatinic acid hydrate H(2)PtCl(6).xH(2)O and pyridine-2-carbaldehyde-oxime (paOH) in the presence of potassium thiocyanate at room temperature (25°) led to the formation of a new Pt(IV) complex with the formula [Pt(SCN)(2)(paO)(2)], (1). Com...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-bendary, Mohamed M., Saleh, Tamer S., Alomari, Mansour M., Ali, Ehab M. M., Davaasuren, Bambar, Jaremko, Mariusz, Babgi, Bandar A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323151/ https://www.ncbi.nlm.nih.gov/pubmed/35889278 http://dx.doi.org/10.3390/molecules27144406

Ejemplares similares

Tuning anticancer properties and DNA-binding of Pt(ii) complexes via alteration of nitrogen softness/basicity of tridentate ligands
por: Al-Rashdi, Kamelah S., et al.
Publicado: (2023)

Tuning the anticancer properties of Pt(ii) complexes via structurally flexible N-(2-picolyl)salicylimine ligands
por: Al-Rashdi, Kamelah S., et al.
Publicado: (2022)

Single crystal, Hirshfeld surface and theoretical analysis of methyl 4-hydroxybenzoate, a common cosmetic, drug and food preservative—Experiment versus theory
por: Sharfalddin, Abeer, et al.
Publicado: (2020)

Alteration of Anticancer and Protein-Binding Properties of Gold(I) Alkynyl by Phenolic Schiff Bases Moieties
por: Babgi, Bandar A., et al.
Publicado: (2021)

Crystal structure of trichlorido(4′-ferrocenyl-2,2′:6′,2′′-terpyridine-κ(3) N,N′,N′′)iridium(III) acetonitrile disolvate
por: Davaasuren, Bambar, et al.
Publicado: (2015)

Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs
por: Huang, Jingjing, et al.
Publicado: (2022)

Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidney
por: Legin, A. A., et al.
Publicado: (2016)

In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent
por: Olszewski, Ulrike, et al.
Publicado: (2009)

Axial functionalisation of photoactive diazido platinum(iv) anticancer complexes
por: Shi, Huayun, et al.
Publicado: (2020)

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity
por: Khoury, Aleen, et al.
Publicado: (2022)

Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism
por: Kozubík, Alois, et al.
Publicado: (2008)

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform
por: Lerchbammer-Kreith, Yvonne, et al.
Publicado: (2023)

Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins
por: Alonso‐de Castro, Silvia, et al.
Publicado: (2018)

Crystal structure of hexakis(dimethyl sulfoxide-κO)manganese(II) tetraiodide
por: Haque, Md Azimul, et al.
Publicado: (2016)

Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs
por: Kastner, Alexander, et al.
Publicado: (2023)

Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs
por: Wong, Daniel Yuan Qiang, et al.
Publicado: (2015)

DNA-Binding and Anticancer Activity of Binuclear Gold(I) Alkynyl Complexes with a Phenanthrenyl Bridging Ligand
por: Alsaeedi, Mona S., et al.
Publicado: (2020)

Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells
por: Olszewski, Ulrike, et al.
Publicado: (2011)

DNA-Binding and Cytotoxicity of Copper(I) Complexes Containing Functionalized Dipyridylphenazine Ligands
por: Alsaedi, Sammar, et al.
Publicado: (2021)

DNA-Binding Capabilities and Anticancer Activities of Ruthenium(II) Cymene Complexes with (Poly)cyclic Aromatic Diamine Ligands
por: Alsaeedi, Mona S., et al.
Publicado: (2020)

Diazido Mixed-Amine Platinum(IV) Anticancer Complexes Activatable by Visible-Light Form Novel DNA Adducts
por: Zhao, Yao, et al.
Publicado: (2013)

New Platinum(IV) and Palladium(II) Transition Metal Complexes of s-Triazine Derivative: Synthesis, Spectral, and Anticancer Agents Studies
por: Al-Khodir, Fatima A. I., et al.
Publicado: (2019)

Anticancer Platinum Drugs Update
por: Ciarimboli, Giuliano
Publicado: (2021)

Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity
por: Zhang, Honglei, et al.
Publicado: (2020)

A Theoretical Study on the Medicinal Properties and Eletronic Structures of Platinum(IV) Anticancer Agents With Cl Substituents
por: Yan, Xiaoyang, et al.
Publicado: (2022)

Dibromidodimethyldipyridineplatinum(IV)
por: Kelly, Mairéad E., et al.
Publicado: (2008)

Urinary biomarkers for early detection of platinum based drugs induced nephrotoxicity
por: Abdelsalam, Mostafa, et al.
Publicado: (2018)

Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast Cancer Cell Lines
por: Predarska, Ivana, et al.
Publicado: (2022)

Chiral discrimination in platinum anticancer drugs.
por: Benedetti, Michele, et al.
Publicado: (2002)

Monofunctional Platinum(II) Anticancer Agents
por: Jin, Suxing, et al.
Publicado: (2021)

Potent Chlorambucil-Platinum(IV) Prodrugs
por: Aputen, Angelico D., et al.
Publicado: (2022)

Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo
por: Schueffl, Hemma, et al.
Publicado: (2021)

Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads
por: Mohammed, Hamdoon A., et al.
Publicado: (2022)

Platinum–gold nanoraspberries as effective photosensitizer in anticancer photothermal therapy
por: Depciuch, J., et al.
Publicado: (2019)

Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes
por: Bolitho, Elizabeth M., et al.
Publicado: (2021)

Toxicity of platinum (IV) salts for cells of pulmonary origin.
por: Waters, M D, et al.
Publicado: (1975)

Improving the anticancer activity of platinum(iv) prodrugs using a dual-targeting strategy with a dichloroacetate axial ligand
por: Liu, Fengfan, et al.
Publicado: (2019)

Anticancer Activity, Reduction Mechanism and G-Quadruplex DNA Binding of a Redox-Activated Platinum(IV)–Salphen Complex
por: Vigna, Vincenzo, et al.
Publicado: (2022)

Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes—A More Selective Anticancer Treatment?
por: Lerchbammer-Kreith, Yvonne, et al.
Publicado: (2023)

Oxidation of the Platinum(II) Anticancer Agent [Pt{(p-BrC(6)F(4))NCH(2)CH(2)NEt(2)}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide
por: Ojha, Ruchika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mkngi6tsgkkn6qdu8v4f18tluf